Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells

Nutrition Research

Volumn 30, Issue 4, 2010, Pages 271-278

  Al Kalaldeh, Jelnar Z ^a   Abu Dahab, Rana ^a   Afifi, Fatma U ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Antiproliferative activity; Culinary herbs; Essential oils; GC MS; Jordan; MCF7

Indexed keywords

ABSINTHOL; ANTINEOPLASTIC AGENT; BETA PHELLANDRENE; BETA PINENE; BETA THUYONE; BORNEOL; CAMPHOR; CARVACROL; CARYOPHYLLENE; CINEOLE; ESSENTIAL OIL; EUGENOL; HUMULENE; LAURUS NOBILIS EXTRACT; LIMONENE; LINALOOL; METHYLEUGENOL; MYRCENE; ORIGANUM SYRIACUM EXTRACT; ORIGANUM VULGARE EXTRACT; PARA CYMENE; PINENE; PLANT EXTRACT; SABINENE; SALVIA TRILOBA EXTRACT; TERPINEN 4 OL; TERPINEOL; TERPINOLENE; THYMOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CELL PROLIFERATION; CELL STRAIN MCF 7; CYTOTOXICITY; DRUG DETERMINATION; HUMAN; HUMAN CELL; IC 50; LAURUS NOBILIS; MASS FRAGMENTOGRAPHY; MEDICINAL PLANT; OREGANO; ORIGANUM SYRIACUM; PRIORITY JOURNAL; SALVIA TRILOBA; SPICE;

ADENOCARCINOMA; ANGIOSPERMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; JORDAN; LAURUS; OILS, VOLATILE; ORIGANUM; PHYTOTHERAPY; PLANT EXTRACTS; RHODAMINES; SALVIA; SPICES; TERPENES;

LAURUS NOBILIS; ORIGANUM SYRIACUM; ORIGANUM VULGARE; SALVIA TRILOBA;

EID: 77953345597     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.04.001     Document Type: Article

References (57)

1. Balunas M., Kinghorn A. Drug discovery from medicinal plants. Life Sci 2005, 78:431-441.
2. Broadhurst C.L., Polansky M.M., Anderson R.A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 2000, 48:849-852.
3. Yeh G.Y., Kaptchuk T.J., Eisenberg D.M., Phillips R.S. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003, 26:1277-1294.
4. Srinivasan K. Spices as influencers of body metabolism: an overview of three decades of research. Food Res Int 2005, 38:77-86.
5. Srinivasan K. Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 2005, 56:399-414.
6. Sylvestre M., Legault J., Dufour D., Pichette A., Lonatin A. Chemical composition and anticancer activity of leaf essential oil of Myrica gale L. Phytomedicine 2005, 12:299-304.
7. Shan B., Cai Y.Z., Brooks J.D., Corke H. The in vitro antibacterial activity of dietary spice and medicinal herb extracts. Int J Food Microbiol 2007, 117:112-119.
8. Cardil V., Russo A., Formisano C., Rigano D., Senatore F., Apostolides Arnold N., et al. Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells. J Ethnopharmacol 2009, 126:265-272.
9. Kamatou G., Van Zyl R., Davids H., Van Heerden F., Lourens A., Viljoen A. Antimalarial and anticancer activities of selected South African Salvia species and isolated compounds from S. radula. S Afr J Bot 2008, 74:238-243.
10. Liu X., Zu Y., Fu Y., Tao L., Gu C., Wang W., et al. Antimicrobial activity and cytotoxicity towards cancer cells of Melaleuca alternifolia (tea tree) oil. Eur Food Res Technol 2009, 229:247-253.
11. Mukherjee A.K., Basu S., Sarkar N., Ghosh A.C. Advances in cancer therapy with plant based natural products. Cur Med Chem 2001, 8:1467-1486.
12. Rates S. Plants as source of drugs. Toxicon 2001, 39:603-613.
13. Mans D., Rocha A., Schwartsmann G. Anticancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anticancer compounds. Oncologist 2000, 5:185-198.
14. Mantle D., Lennard T.W., Pickering A.T. Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adverse Drug React Toxicol Rev 2000, 19:223-240.
15. Abu-Irmaileh B., Afifi F. Treatment with medicinal plants in Jordan. Dirasat 2000, 27:53-74.
16. Itharat A., Houghton P.J., Eno-Amooquaye E., Burke P.J., Sampson J.H., Raman A. In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol 2004, 90:33-38.
17. Adams R.P. Identification of essential oil components by gas chromatography/mass spectroscopy 1995, Allured publ. Corp. Carol Stream, Illinois.
18. Kilic A., Hafizoglu H., Kollmannsberger H., Nitz S. Volatile constituents and key odorants in leaves, buds, flowers, and fruits of Laurus nobilis L. J Agric Food Chem 2004, 52:1601-1606.
19. Macchioni F., Perrucci S., Cioni P., Morelli I. Composition and acaricidal activity of Laurus novocanariensis and Laurus nobilis essential oils against Psoroptes cuniculi. JEOR 2006, 18:111-114.
20. Ozek T., Bozan B., Baser K.H.C. Supercritical CO2 extraction of volatile components from leaves of Laurus nobilis L. Chem Nat Compd 1998, 34:668-671.
21. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants 1993, Intercept Ltd, Andover.
22. Fleisher A., Fleisher Z. Chemical composition of Origanum syriacum L. essential oil. Aromatic plants of the Holy Land and the Sinai. JEOR 1991, 3:121-123.
23. Arnold N., Bellomaria B., Valentini G. Composition of the essential oil of three different species of Origanum in the Eastern Mediterranean. JEOR 2000, 12:192-196.
24. D'Antuono L.F., Galletti G.C., Bocchini P. Variability of essential oil content and composition of Origanum vulgare L populations from a North Mediterranean area (Liguria Region, Northern Italy). Ann Bot 2000, 86:471-478.
25. Baser K.H.C., Kurkcuoglu M., Demirci B., Ozek T. The essential oil of Origanum syriacum L var sinaicum (Boiss) Ietswaart. Flavour Fragrance J 2003, 18:98-99.
26. Figuérédo G., Cabassu P., Chalchat J.C., Pasquier B. Studies of Mediterranean oregano populations-V. Chemical composition of essential oils of oregano: Origanum syriacum L var bevanii (Holmes) Ietswaart, O. syriacum L. var. sinaicum (Boiss) Ietswaart, and O. syriacum L. var. syriacum from Lebanon and Israel. Flavour Fragrance J 2005, 20:164-168.
27. Loizzo M.R., Menichini F., Conforti F., Tundis R., Bonesi M., Saab A.M., et al. Chemical analysis, antioxidant, anti-inflammatory and anticholinesterase activities of Origanum ehrenbergii Boiss and Origanum syriacum L. essential oils. Food Chem 2009, 117:174-180.
28. Lukas B., Schmiderer C., Franz C., Nowak J. Composition of essential oil compounds from different Syrian populations of Origanum syriacum L. (Lamiaceae). J Agric Food Chem 2009, 57:1362-1365.
29. Alma M.H., Mavi A., Yildirim A., Digrak M., Hirata T. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biol Pharmacol Bull 2003, 26:1725-1729.
30. Sener O., Arslan M., Demirel N., Uremis I. Insecticidal effects of some essential oils against the confusedflour beetle (Tribolium confusum du Val) (Col.: Tenebrinoidea) in stored wheat. Asian J Chem 2009, 21:3995-4000.
31. Hristova R., Ristc M., Brkic D., Stefkov G., Kulevanova S. Comparative analysis of essential oil composition of Origanum vulgare from Macedonia and commercially available Origani herba. Acta Pharm 1999, 49:299-305.
32. Tkachenko K.G., Tkachev A.V., Koroljuk E.A. Component composition of essential oil from Origanum vulgare L, grown in Leningrad region. Rastit Resur 2002, 38:97-101.
33. Lukas B., Schmiderer C., Mitteregger U., Chlodwig F., Novak J. Essential oil compounds of Origanum vulgare L (Lamiaceae) from Corsica. Nat Prod Comm 2008, 3:1127-1131.
34. De Martino L., De Feo V., Formisano C., Mignola E., Senatore F. Chemical composition and antimicrobial activity of the essential oils from three chemotypes of Origanum vulgare L spp Hirtum (link) Ietswart growing wild in Campania (Southern Italy). Molecules 2009, 14:2735-2746.
35. Prieto J., Iacopini P., Cioni P., Chericoni S. In vitro activity of the essential oils of Origanum vulgare, Satureja montana and their main constituents in peroxynitrite-induced oxidative processes. Food Chem 2007, 104:889-895.
36. Ronyai E., Simandi B., Veress T., Lemberkovics E., Patiaka D. Comparison between the essential oil and supercritical carbon dioxide extract of Salvia fruticosa Mill. JEOR 1999, 11:499-502.
37. Skoula M., Abbes J.A., Johnson C.B. Genetic variation of volatiles and rosmarinic acid in populations of Salvia fruticosa Mill growing in Crete. Biochem Syst Ecol 2000, 28:551-561.
38. Pitarokili D., Tzakou O., Loukis A., Harvala C. Volatile metabolites from Salvia fruticosa as antifungal agents in soil-borne pathogens. J Agric Food Chem 2003, 51:3294-3301.
39. Kosar M., Tunalier Z., Oezek T., Kuerkcueoglu M., Baser K.H.C. A simple method to obtain essential oils from Salvia triloba L and Laurus nobilis L by using microwave assisted hydrodistillation. Z Naturforsch C 2005, 60:501-504.
40. Delamare A., Moschen-Pistorello I., Artico L., Atti-Serafini L., Echeverrigaray S. Antibacterial activity of the essential oils of Salvia officinalis L and Salvia triloba L cultivated in south Brazil. Food Chem 2007, 100:603-608.
41. Papageorgiou V., Gardeli C., Mallouchos A., Papaioannou M., Komaitis M. Variation of the chemical profile and antioxidant behavior of Rosmarinus officinalis L and Salvia fruticosa Miller grown in Greece. J Agric Food Chem 2008, 56:7254-7264.
42. Perry N.B., Anderson R.E., Brennan N.J., Douglas M.H., Heaney A.J., McGrimpsey J.A., et al. Essential oil from Dalmatian sage (Salvia officinalis L), variations among individuals, plant parts, seasons and sites. J Agric Food Chem 1999, 47:2048-2054.
43. Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nature Rev Cancer 2006, 6:813-823.
44. Boik J. Natural compounds in cancer therapy 2001, Oregon Medical Press, Minnesota.
45. Barla A., Topçu G., Öksüz S., Tümen G., Kingston D. Identification of cytotoxic sesquiterpenes from Laurus nobilis L. Food Chem 2007, 104:1478-1484.
46. Loizzo M.R., Tundis R., Menichini F., Saab A.M., Statti G.A., Menichini F. Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models. Anticancer Res 2007, 27:3293-3299.
47. Kaileh M., Berghe W.V., Boone E., Essawi T., Haegeman G. Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity. J Ethnopharmacol 2007, 113:510-516.
48. Hinneburg I., Damien Dorman H.J., Hiltunen R. Antioxidant activities of extracts from selected culinary herbs and spices. Food Chem 2006, 97:122-129.
49. Lantto T.A., Colucci M., Zavadova V., Hiltunen R., Raasmaja A. Cytotoxicity of curcumin, resveratrol and plant extracts from basil, juniper, laurel and parsley in SH-SY5Y and CV1-p cells. Food Chem 2009, 117:405-411.
50. Alkofahi A., Batshoun R., Owais W., Najib N. Biological activity of some Jordanian medicinal plant extracts Part II. Fitoterapia 1997, LXVIII:163-168.
51. Bakkali F., Averbeck S., Averbeck D., Zhiri A., Idaomar M.A. Cytotoxicity and gene induction by some essential oils in the yeast Saccharomyces cerevisiae. Mut Res 2005, 585:1-13.
52. Chinou I., Liolios C, Moreau D., Roussakis C Cytotoxic activity of Origanum dictamnus. Fitoterapia 2007, 78:342-344.
53. Alkofahi A., Batshoun R., Owais W., Najib N. Biological activity of some Jordanian medicinal plant extracts. Fitoterapia 1996, LXVII:435-442.
54. Meng L.H., Zhang J.S.H., Jian D. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes. Biochem Pharmacol 2001, 62:733-741.
55. Lee W.Y., Chiu L.C., Yeung J.H. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation. Food Chem Toxicol 2008, 46:328-338.
56. Fiore G., Nencini C., Cavallo F., Capasso A., Bader A., Giorgi G., et al. In vitro antiproliferative effect of six Salvia species on human tumor cell lines. Phytother Res 2006, 20:701-703.
57. Abu-Dahab R., Afifi F. Antiproliferative activity of selected medicinal plants of Jordan against a breast adenocarcinoma cell line (MCF7). Sci Pharm 2007, 75:121-136.